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Available online xxxxA reduction in the activity of GABAA receptors, particularly α5 subunit-containing GABAA receptors
(α5GABAARs), has been implicated in the etiology of Autism Spectrum Disorders (ASD). Genetically modiﬁed
mice that lackα5GABAARs (Gabra5−/−) exhibit autism-like behaviors and both enhanced and impaired learning
andmemory, depending on the behavioral task. The aim of this study was to examine the electroencephalogram
(EEG) activity and sleep-wake behaviors inGabra5−/−mice andwild-typemice. In addition, since some individ-
uals with ASD can exhibit elevated innate immune response, mice were treated with lipopolysaccharide (LPS;
125 mg/kg intraperitoneal injection) or vehicle and EEG and sleep-wake patterns were assessed. The results
showed that Gabra5−/−mice (n= 3) exhibited elevated 0–2 Hz EEG activity during all sleep-wake states (all
p b 0.04), decreased 8–12Hz EEG activity during REM sleep (p=0.04), and decreased sleep spindles under base-
line conditions compared to wild-type controls (n=4) (all p ≤ 0.03). Alterations in EEG activity and sleep-wake
behavior were identiﬁed in Gabra5−/−mice following treatment with LPS, however these changes were similar
to those in wild-type mice. Our ﬁndings support the hypothesis that reduced α5GABAAR activity contributes to
an ASD phenotype. The results also suggest that Gabra5−/− mice may serve as an animal model for ASD, as
assessed through EEG activity and sleep-wake behaviors.
© 2016 Published by Elsevier Inc.Keywords:
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Sleep1. Introduction
γ-Aminobutyric acid type A (GABAA) receptors mediate the major
inhibitory neurotransmitter in the mammalian brain. These
heteropentameric ionotropic receptors are formed from 19 different
subunits (α1-6, β1-3, γ1-3, δ, ε, θ, π, ρ1-3) and the majority consist of
two α subunits, two β subunits and one γ or δ subunit (Olsen and
Sieghart, 2009). GABAA receptors that contain the α5 subunit
(α5GABAA) are of particular interest due to their restricted pattern of
distribution and unique physiological and pharmacological properties
(Lee and Maguire, 2014; Chebib and Johnston, 1999; Lingford-Hughes
et al., 2002). Extrasynaptic α5GABAA receptors are expressed in high
levels in the hippocampus and at lower levels in the cortex, olfactoryiences Building, 1 King's College
cal Sciences Building, 1 King's
ser),
t al., Reduced expression of α
2016), http://dx.doi.org/10.10bulb and hypothalamus. Activation of these receptors generates a
tonic inhibitory conductance that reduces network excitability and syn-
aptic plasticity (Bai et al., 2001; Martin et al., 2010; Caraiscos et al.,
2004).α5GABAA receptors also play a trophic role that regulates the de-
velopment of neural circuits (Lu et al., 2014). Dysregulation of
extrasynaptic GABAA receptors has been implicated in a variety of disor-
ders including epilepsy, fragile X mental retardation, mood disorders
and anesthetic-induced long-term memory disorders (Poulter et al.,
1999; Houser and Esclapez, 2003; Pavlov and Walker, 2013; Curia
et al., 2009; Olmos-Serrano et al., 2010; Brickley Stephen and Mody,
2012; Luscher et al., 2011; Zurek et al., 2014; Walker et al., 2012).
Mice lacking the gene that encodes theα5 subunit gene (Gabra5−/−
) exhibit several intriguing phenotypes including autism-like behaviors
and both enhanced and impaired performance on different learning and
memory tasks (Martin et al., 2010). Compared to wild-type controls,
Gabra5−/− mice exhibit reduced social contacts, impaired executive
function, reduced vocalization, and impaired maternal retrieval (Zurek
et al., 2016). Such autism-like behaviors are noteworthy as reduced
function and/or expression of GABAA receptors has been implicated in
Autism Spectrum Disorders (ASDs) (Zurek et al., 2016; Piton et al.,5GABAA receptors elicits autism-like alterations in EEG patterns and
16/j.ntt.2016.10.009
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copy number variant associated with ASD is a duplication of the
q11.2-13 region of chromosome 15 (Moreno-De-Luca et al., 2013;
Hogart et al., 2010). This region of the gene encodes for the α5, β3,
and γ3 subunits of the GABAAR (Klauck, 2006). Rare variants in the
gene that encodes the α5 subunit have been identiﬁed in patients
with ASD (Zurek et al., 2016). In addition, screening of sequencing
data from a cohort of 396 Canadian probands identiﬁed potential mis-
sense mutations in GABRA5, the gene for the α5-subunit expressing
GABAAR (α5GABAAR) as well as RDX, the gene that encodes the
α5GABAAR anchoring protein, radixin (Zurek et al., 2016). Collectively,
these ﬁndings suggest that a reduction in the function of α5GABAARs
may contribute to the pathophysiology underlying ASD.
The primary aim of this studywas to characterize the electroenceph-
alogram (EEG) activity in Gabra5−/−mice. The spectral composition of
the EEG is of interest as it reﬂects the synchronized activity of neuronal
networks and has been proposed as a biomarker for ASD (Wang et al.,
2013). We also studied sleep and wake patterns in Gabra5−/−mice as
high-functioning adults with ASD exhibit a number of alterations in
sleep-wake architecture including fragmentation of sleep, elevated noc-
turnal awakenings, reduced sleep spindle activity, and decreased REM
sleep (Limoges et al., 2005; Godbout et al., 2000; Daoust et al., 2004).
A secondary aim of this study was to examine the response of
Gabra5−/− mice to an inﬂammatory challenge. Individuals with ASD
can exhibit exaggerated immune responses and elevated baseline levels
of circulating cytokines are present in cerebrospinal ﬂuid (Patterson,
2009; Vargas et al., 2005; Chez et al., 2007). Consistent with the notion
that an exaggerated immune responses contribute to ASD, a mouse
model of ASD, which involves injection of valproic acid, identiﬁed ele-
vated baseline levels of plasma cytokines and an exacerbated immune
response to an inﬂammatory challenge (Lucchina and Depino, 2014).
Inﬂammatory processes may contribute to both the initial development
of ASD and on-going behavioral abnormalities.
Overall, we predicted that the spectral composition of the EEG re-
corded and sleep patterns in Gabra5−/−mice would differ from those
of wild-type mice and such differences would mimic those identiﬁed
in individuals with ASD. We also hypothesized that LPS would elicit
the prototypic changes in EEG and sleep-wake behavior that are associ-
ated with inﬂammation and that these changes would be exaggerated
in the Gabra5−/−mice compared to wild-type controls.
2. Materials and methods
2.1. Animal Care
Experiments were performed on 3–6 month old male Gabra5−/−
mice (n = 3) and their wild-type C57BL/6 × SvJ129 background con-
trols (n= 4). Gabra5−/−mice were generated as previously described
(Collinson et al., 2002). Mice were housed with their littermates in ﬁl-
tered cages with controlled lighting (lights on 0700 h, off at 1900 h)
and they had free access to sterile food and water. All procedures
were performed in compliance with the requirements of the Canadian
Council on Animal Care andwere approved by the University of Toronto
Animal Care Committee.
2.2. Surgery
All surgical procedures were performed under aseptic conditions
with mice under isoﬂurane-induced general anesthesia (3% for induc-
tion and 1.5–2% formaintenance). Implantation of EEG and electromyo-
gram (EMG) electrodes was performed as previously described
(Mesbah-Oskui et al., 2014). Brieﬂy, two insulated stainless steel wires
were implanted subcutaneously into the dorsal neck muscles. Stainless
steel EEG electrodes were positioned onto the left frontal cortex, right
anterior parietal cortex, and left cerebellum (ground electrode) to pro-
vide a bipolar EEG recording with respect to a common referencePlease cite this article as: Mesbah-Oskui, L., et al., Reduced expression of α
sleep-wake behavior, Neurotoxicol Teratol (2016), http://dx.doi.org/10.10electrode. All electrodes were connected to pins in a miniature connec-
tor (ED90267-ND, Digi-Key Co., Thief River Falls, MN) that was secured
to the skull with dental acrylic. Micewere given at least 9 days to recov-
er from surgery prior to habituation and experiments. Following sur-
gery, mice were housed individually in their home cages.
2.3. Habituation
Recordings were performed in noise-attenuated and electrically
shielded chambers (EPC-010, BRS/LVE Inc., Laurel, MD). Recording
chambers housed a large, open-topped Plexiglas bowl (Rodent Bowl,
MD, 1514, BAS Inc., West Lafayette, IN). Inside the recording environ-
ment, mice had ad libitum access to food and water. A video camera
wasmounted onto the ceiling of the recording chamber to permit visual
monitoring of mouse behavior throughout the recordings. These video
ﬁles were manually reviewed to conﬁrm scoring of sleep-wake behav-
ior.Micewere habituated for 4 consecutive days as previously described
(Mesbah-Oskui et al., 2014). On the ﬁfth day, the mice were left over-
night and experimental recordings commenced the following morning.
The recording enclosure was cleaned with a 70% ethanol solution be-
tween each recording session, and also fresh bedding and food was
laid down between sessions.
2.4. Experimental protocol
The full experimental protocol occurred over a two-day period. On
the morning of the ﬁrst experimental day, at approximately 1000 h,
themicewere gently restrained and they received an intraperitoneal in-
jection of saline. On the morning of the second experimental day, mice
were again gently restrained and received an intraperitoneal injection
of lipopolysaccharide (LPS; 125 μg/kg) at the same approximate time
as the previous saline injection. All experimental recordings were per-
formed during the immediate 7-hour period following injection (from
approximately 1000 h to 1700 h). This period corresponds to the light
cycle, a period when mice normally sleep. In all of the mice studied
the data collected during the ﬁrst hour following injectionwere exclud-
ed from analysis to avoid any potential confound associated with the
acute injection.
2.5. Signal acquisition and analysis of sleep-wake states
Signals were acquired using Spike 2 software (1401 interface, CED
Ltd., Cambridge, UK) as previously described (Mesbah-Oskui et al.,
2014). Sleep-wake stateswere scored using an automatic scoring proto-
col by analyzing the EEG and EMG signals in consecutive 5-second
epochs. Importantly, the accuracy of the scoring procedure was con-
ﬁrmed manually for each epoch across the whole recording period.
The amount of time spent in wakefulness, non-rapid eye movement
(non-REM) sleep, and REM sleep was calculated as a percentage of the
total recording time in 2-hour blocks for each treatment for each animal
up until 7 hour post-injection.
Electrocortical activity was analyzed using a fast Fourier transform
algorithm (SUDSA22 script, Spike 2 software, CED Inc.). Power spectra
were generated for each 5-second epoch of the EEG that was scored
for sleep-wake state through the analysis of overlapping 1024-sample
segments that were windowed with a Hanning function. Each 5-
second epoch was analyzed for power in 6 bandwidths: low delta (0–
2 Hz), delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta (12–
30 Hz), and sigma (10–15 Hz). The absolute power in each bandwidth
was divided by the total power (1–30 Hz) in each epoch and the nor-
malized powers were sorted according to their corresponding sleep-
wake state. The mean power in each frequency band for each sleep-
wake state was then calculated for each treatment for each subject.
Epochs that contained movement artifacts, including those that arose
during grooming and eating behaviors, were visually identiﬁed and re-
moved from the spectral analyses. The incidence and duration of5GABAA receptors elicits autism-like alterations in EEG patterns and
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tines inMATLAB. These routines have been described in detail previous-
ly (Mesbah-Oskui et al., 2014).
2.6. Statistical analysis
The effects of genotype and the innate immune response to LPS on
sleep-wake structure, electrocortical activity, and spindle-like oscilla-
tions were assessed using a 2-way repeated measures analysis of vari-
ance (RM ANOVA), with the factors being: (Olsen and Sieghart, 2009)
genotype (i.e., Gabra5−/− versus wild-type) and (Lee and Maguire,
2014) treatment (i.e., vehicle versus LPS). Bonferonni-corrected p values
were used to test statistical signiﬁcance when post hoc comparisons
were performed. Differences were considered signiﬁcant if p b 0.05.
Analyses were performed using SigmaStat software (SPSS, San Jose,
CA). Data are expressed as mean ± standard error of the mean (SEM).
3. Results
3.1. Slow EEG activity
Slow (i.e., 0–2 Hz and 1–4 Hz) EEG activity in Gabra5−/−mice was
analyzed ﬁrst, given the existing association between ASD and alter-
ations in low frequency EEG activity (Cantor et al., 1986; Chan et al.,
2007; Pop-Jordanova et al., 2010; Stroganova et al., 2007). During
non-REM sleep Gabra5−/−mice exhibited increased 0–2 Hz power rel-
ative to wild-type mice during each of the three time-bins post-
injection (i.e., 1–3, 3–5, and 5–7 h post injection, each F1, 5 ≥ 13.75,
p b 0.015; Figs. 1 and 2Ai). This ﬁnding is consistent with the ASD-like
behavioral phenotype identiﬁed in Gabra5−/− mice (Zurek et al.,
2016). This difference 0–2 Hz EEG activity between genotypes was
also present during wakefulness at each time-bin (all F1, 5 ≥ 7.85,
p b 0.039; Fig. 2Bi) and REM sleep during the ﬁrst time-bin (F1, 5 =500 µV
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Fig. 1. Exemplar recordings from awild-typemouse (left) andGabra5−/−mouse (right) 3–5 h a
in the EEG of the Gabra5−/−mouse relative to the wild-type mouse. Also note the lower level
spectrogram sections located directly beneath the hypnogram traces (i.e., the dark blue color
mouse). NREM: non-REM. (For interpretation of the references to color in this ﬁgure legend, th
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sleep-wake behavior, Neurotoxicol Teratol (2016), http://dx.doi.org/10.1027.75, p= 0.003; Fig. 2Ci). The increased 0–2 Hz activity in the subse-
quent time-bins in REM sleep was of borderline statistical signiﬁcance
in the Gabra5−/− mice (range of F1, 5 = 6.39 to 6.50, range of p =
0.051 to 0.053; Fig. 2Ci).
There was no signiﬁcant difference in 1–4 Hz (i.e., δ frequency) EEG
power between Gabra5−/−mice and wild-type mice at any time point
during non-REM sleep (all F1, 5 ≤ 2.03, p ≥ 0.21; Fig. 2Aii), wakefulness
(all F1, 5 ≤ 1.06, p ≥ 0.35; Fig. 2Bii), or REM sleep (all F1, 5 ≤ 5.46,
p ≥ 0.06; Fig. 2Cii), i.e., the differences between genotypes in slow EEG
frequencies was restricted to the 0–2 Hz range.
Intraperitoneal injection of LPS produced a genotype-independent
increase in 1–4 Hz EEG power during non-REM sleep in the ﬁnal two-
hour time-bin (i.e., 5–7 h post LPS, F1, 5 = 11.48, p = 0.02; Fig. 2Aii).
These ﬁndings are consistent with previous reports characterizing the
effect of immune challenge with LPS on EEG activity, and the time for
the onset of these EEG differences to manifest (Imeri and Opp, 2009).
Slow 0–2Hz EEG activity and 1–4Hz EEG activitywere also signiﬁcantly
elevatedwith LPS duringwakefulness (Fig. 2Bi and ii, respectively). Spe-
ciﬁcally, LPS elicited an increase in 0–2 Hz EEG activity in the ﬁnal two
hour time-bin (F1, 5 = 6.98, p = 0.04; Fig. 2Bi) and an increase in 1–
4 Hz EEG activity in the ﬁnal 4 h of recording (both F1, 5 ≥ 8.57,
p ≤ 0.03; Fig. 2Bii) duringwakefulness. Therewere no LPS-induced alter-
ations in 0–2 Hz and 1–4 Hz EEG power during REM sleep (Fig. 2Ci and
ii, respectively).
The differences in 0–2 Hz power between wild-type and Gabra5−/−
micewere still evident when total average power in this band was ana-
lyzed, i.e., average power calculated for the entire recording period. Spe-
ciﬁcally, 0–2 Hz EEG power was higher in Gabrd−/− mice with both
saline and LPS relative to wild-type mice during non-REM sleep (F1,
5 = 16.14, p = 0.01; Fig. 2Aiii), wakefulness (F1, 5 = 14.39, p = 0.01;
Fig. 2Biii), and REM sleep (F1, 5 = 8.13, p= 0.04; Fig. 2Ciii). The effect
of LPS on1–4Hzpower duringwakefulnesswas also evident in compar-
isons of total average 1–4 Hz power (F1, 5 = 6.9, p= 0.04; Fig. 2Biv).0 dB
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During non-REM sleep, wild-typemice andGabra5−/−mice exhibit-
ed comparable 4–8 Hz (all F1, 5 ≤ 0.20, p ≥ 0.67), 8–12 Hz (all F1, 5 ≤ 5.56,
p ≥ 0.06) and 12–30 Hz (all F1, 5 ≤ 6.0, p ≥ 0.06) EEG activity (Fig. 3A–C).
Similarly, in wakefulness there were no differences in genotype in 4–
8 Hz (all F1, 5 ≤ 0.26, p ≥ 0.63), 8–12 Hz (all F1, 5 ≤ 2.28, p ≥ 0.19), andPlease cite this article as: Mesbah-Oskui, L., et al., Reduced expression of α
sleep-wake behavior, Neurotoxicol Teratol (2016), http://dx.doi.org/10.1012–30 Hz (all F1, 5 ≤ 0.85, p ≥ 0.40) EEG activity (Fig. 3A–C). Consistent
with these ﬁndings during non-REM sleep and wakefulness,
Gabra5−/− mice exhibited unaltered 4–8 Hz (all F1, 5 ≤ 1.60, p ≥ 0.26)
and 12–30 Hz (all F1, 5 ≤ 1.05, p ≥ 0.35) power during REM sleep
(Fig. 3A–C).
Importantly, however, Gabra5−/−mice exhibited signiﬁcantly lower
8–12 Hz EEG power during the ﬁrst two hour recording period in REM5GABAA receptors elicits autism-like alterations in EEG patterns and
16/j.ntt.2016.10.009
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5L. Mesbah-Oskui et al. / Neurotoxicology and Teratology xxx (2016) xxx–xxxsleep (F1, 5 = 7.00, p= 0.04; Fig. 3B), a ﬁnding consistent with EEG ac-
tivity patterns associated with ASD (Cantor et al., 1986; Chan et al.,
2007; Pop-Jordanova et al., 2010; Stroganova et al., 2007). There were
no signiﬁcant differences between genotypes for total average power
(i.e., average power calculated for the entire recording period) in the
4–8 Hz (all F1, 5 ≤ 0.08, p ≥ 0.79), 8–12 Hz (all F1, 5 ≤ 5.39, p ≥ 0.07),
and 12–30 Hz (all F1, 5 ≤ 3.67, p ≥ 0.11) frequency bands in each of wak-
ing, non-REM and REM sleep (data not shown).
Intraperitoneal injection of LPS elicited a genotype-independent re-
duction in 8–12 Hz activity in the ﬁnal two hour time-bin (i.e., 5–7 hour
post-injection) during non-REM sleep (F1, 5 = 7.86, p= 0.04; Fig. 3B).
Similarly, LPS elicited a reduction in 12–30 Hz EEG activity in the ﬁnal
4 h of recording (i.e., 3–7 hour post-injection) during non-REM sleep
(F1, 5 ≥ 6.73, p ≤ 0.04; Fig. 3C). LPS also elicited a reduction in 8–12 Hz
power during wakefulness during the ﬁnal 4 h of recording (F1,
5 ≥ 6.91, p ≤ 0.04; Fig. 3B). There was no signiﬁcant change in fast fre-
quency EEG activity (i.e., 4–8, 8–12, or 12–30Hz) following LPS injection
during REM sleep (all F1, 5 ≤ 3.27, p ≥ 0.17; Fig. 3A–C).Please cite this article as: Mesbah-Oskui, L., et al., Reduced expression of α
sleep-wake behavior, Neurotoxicol Teratol (2016), http://dx.doi.org/10.103.3. Sleep Spindle-like Oscillations
Gabra5−/− mice exhibited lower 10–15 Hz (i.e., sigma frequency)
EEG activity during non-REM sleep compared to wild-type mice (F1,
5 = 7.71, p = 0.04; Fig. 4A). Given that sigma power is typically used
as a surrogatemeasure of sleep spindle activity, we next examined indi-
vidual spindle-like events to identify if there were any genotypic differ-
ences in the incidence or duration of spindle-like oscillations. Consistent
with the lower 10–15 Hz power, Gabra5−/−mice exhibited shorter du-
ration spindle-like oscillations relative towild-typemice (all F1, 5 ≥ 8.78,
p ≤ 0.03; Fig. 4B). However, therewere no differences in the incidence of
spindle-like oscillations between genotypes across each time-bin (each
F1, 5 ≤ 3.61, p ≥ 0.12).
LPS elicited a reduction 10–15 Hz power during non-REM sleep in
the ﬁnal 2 h of recording (i.e., 5–7 hour post-injection; F1, 5 = 6.82,
p= 0.04; Fig. 4A). This reduction of 10–15 Hz power with LPS was fur-
ther associated with a reduction in the incidence of spindle-like oscilla-
tions in the ﬁnal 4 h of recording (i.e., 3–7 hour post-injection; F1,5GABAA receptors elicits autism-like alterations in EEG patterns and
16/j.ntt.2016.10.009
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spindle-like oscillation duration (all F1, 5 ≤ 1.51, p ≥ 0.27; Fig. 4B).
3.4. Sleep-wake state duration
There were no differences between the Gabra5−/− and wild-type
mice in the total amount of non-REM sleep (all F1, 5 ≤ 1.66, p ≥ 0.25;
Fig. 5A), wakefulness (all F1, 5 ≤ 2.19, p ≥ 0.20; Fig. 5B), or REM sleep
(all F1, 5 ≤ 0.83, p ≥ 0.40; Fig. 5C). Importantly, consistent with the iden-
tiﬁed effects of inﬂammation on sleep-wake duration inmice, therewas
a signiﬁcant reduction in the amount of REM sleep following injection of
LPS in the ﬁrst two time bins following injection (i.e., 1–5 h, both F1,
5 ≥ 7.01, p b 0.04; Fig. 5C) (Imeri and Opp, 2009). LPS did not elicit any
alterations in the amounts of non-REM sleep at any of the time intervals
post-injection (F1, 5 ≤ 0.93, p ≥ 0.38; Fig. 5A) or wakefulness (F1, 5 ≤ 2.99,
p ≥ 0.14; Fig. 5B).
4. Discussion
This report is the ﬁrst to identify abnormal EEG activity patterns in
Gabra5−/− mice. Speciﬁcally, mice that lack extrasynaptic α5GABAAR
exhibit signiﬁcant enhancements of slow frequency EEG activity at
baseline when compared to wild-type controls, so much so that it was
obvious both in the spectrograms (Fig. 1) and the raw EEG traces.
Such slow frequency (i.e., ≤2 Hz) activity in the EEG is posited to arise
through a complex interaction between pyramidal neurons and local in-
hibitory neurons in the cortex (Steriade et al., 1993; Timofeev and1-3
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where α5GABAARs are particularly heavily expressed, also exhibits a
slowoscillation that is similar to, and coordinatedwith, slowoscillations
in the cortex (Wolansky et al., 2006; Sur et al., 1999). Coordinated activ-
ity between the hippocampus and cortex during non-REM sleep is asso-
ciated with memory consolidation and disruption of this coordination
could lead to impaired memory (Wang and Morris, 2010). Importantly,
Gabra5−/−mice exhibit a number of behavioral abnormalities that are
consistent with alterations in the coordination of slow frequency activ-
ity between the hippocampus and cortex. For example, while
Gabra5−/− mice perform better on the Morris water maze, a
hippocampus-dependent spatial learning task, cognitive ﬂexibility is re-
duced (Zurek et al., 2016; Collinson et al., 2002; Engin et al., 2015; Engin
et al., 2013). Gabra5−/−mice exhibit impaired reversal learning on the
Morris water maze and also impaired learning in the puzzle maze
(Zurek et al., 2016; Engin et al., 2015; Engin et al., 2013). Thus, the ele-
vation in 0–2 Hz EEG activity identiﬁed in Gabra5−/−mice is associated
with both faster spatial learning and impaired reversal of learning and
executive function. This complex behavioral proﬁle, where one form
ofmemory (or several) is enhancedwhile others are impaired, is consis-
tent with the ASD-like phenotype attributed to Gabra5−/−mice (Zurek
et al., 2016).
The remaining alterations in EEG activity identiﬁed in theGabra5−/−
mice are also consistent with an ASD-like phenotype. Speciﬁcally, the
reduction in 8–12 Hz power identiﬁed in the Gabra5−/− mice during
REM sleep and also reduced on average, though not statistically signiﬁ-
cant, during non-REM sleep andwaking, is similar to patterns identiﬁed3-5 5-7
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duced across frontal, occipital, parietal, and temporal brain regions in
some individuals with ASD (Cantor et al., 1986; Chan et al., 2007;
Murias et al., 2007; Dawson et al., 1995). Gabra5−/−mice also exhibit
reduced 10–15 Hz power during non-REM sleep and this corresponds
with sleep spindle-like oscillations of a shorter duration than those
identiﬁed in wild-type mice. This ﬁnding is consistent with the reduc-
tion in sleep spindles during Stage 2 sleep identiﬁed in ASD (Limoges
et al., 2005; Godbout et al., 2000; Daoust et al., 2004). There are a num-
ber of additional alterations in sleep-wake behavior associated with
ASD, which we did not (or could not) identify in Gabra5−/− mice;
such alterations include reduced latency to REM sleep, reduced eye
movements during REM sleep, increased muscle twitches during
sleep, alterations in the amount of Stage 1 sleep, and lack of dreaming
as reported upon waking from REM sleep (Limoges et al., 2005;
Godbout et al., 2000; Daoust et al., 2004; Elia et al., 2000; Miano et al.,
2007).
The alterations in EEG activity identiﬁed in Gabra5−/− mice also
have some interesting similarities to alterations in EEG activity patterns
associatedwith reduced expression of another subtype of extrasynaptic
GABAARs. Speciﬁcally, δ-subunit expressing GABAAR (δGABAAR) knock-
outmice (Gabrd−/−) exhibit elevated low frequency EEG activity during
both non-REM sleep and wakefulness and lower 10–15 Hz power dur-
ing non-REM sleep.(Mesbah-Oskui et al., 2014) Unlike the Gabra5−/−
mice, however, where lower 10–15 Hz power was associated with
shorter duration sleep spindles, the reduced 10–15 Hz power identiﬁed
in Gabrd−/−micewas associatedwith reduced density of sleep spindles
and no alterations in their duration (Mesbah-Oskui et al., 2014). This
difference suggests that deletion of α5GABAARs impairs the propaga-
tion of sleep spindles, while deletion of δGABAAR impairs their genera-
tion. These ﬁndings are likely the result of differences in the
expression patterns of α5GABAARs that are heavily expressed in the
hippocampus, whereas δGABAARs are heavily expressed in the thala-
mus (Sur et al., 1999; Bonin et al., 2007; Peng et al., 2002). Like the
Gabra5−/− mice, Gabrd−/− mice also exhibit no alterations in global
sleep-wake behavior. Collectively, it appears that reduced expression
of extrasynaptic GABAARs is associated with increased low frequency
EEG activity and decreased sleep spindle activity. Given the role of
these receptors in mediating a persistent, tonic inhibitory current and
the association of between increased tonic inhibition and increased
low frequency EEG activity, this ﬁnding is likely attributable to compen-
satory changes in the expression of other channels or receptors
(Mesbah-Oskui et al., 2014; Farrant and Nusser, 2005). Up-regulation
of two-pore domain potassium channels, which can also elicit a tonic in-
hibition through leakage of potassium, has been posited as a potential
compensatory mechanism (Brickley et al., 2001).
Following treatment with LPS, a number of alterations in EEG activ-
ity and sleep-wake behavior were identiﬁed that are consistent with
previous reports (Imeri and Opp, 2009; Lancel et al., 1996; Opp, 2005).
Speciﬁcally, LPS elicits an increase in 1–4 Hz power during non-REM
sleep and wakefulness, a decreased incidence of sleep spindles, and re-
duced REM sleep. These effects of LPS on EEG activity and sleep-wake
behavior have been identiﬁed in a number of species including mice,
rats, rabbits, and sheep (Imeri and Opp, 2009; Lancel et al., 1996; Opp,
2005). Notably, we did not identify any alterations in the amount of
non-REM sleep with LPS, in contrast to other reports where LPS in-
creased the amount of non-REM sleep in mice (Toth and Opp, 2001).
Importantly, the study where LPS was associated with an increase in
the amount of non-REM sleep in mice utilized higher doses of LPS (all
mice received 10 μg in contrast to the present study, where mice re-
ceived 125 μg/kg which typically approximated to 3.8 μg). Notably, the
current study utilized a small sample size (wildtype mice, n = 4;
Gabra5−/−mice, n= 3). However, given the consistency of the results
between genotypes, the data provide compelling evidence that
Gabra5−/− mice exhibit alterations in EEG activity compared to
wildtype mice. Future investigations that utilize a larger sample sizePlease cite this article as: Mesbah-Oskui, L., et al., Reduced expression of α
sleep-wake behavior, Neurotoxicol Teratol (2016), http://dx.doi.org/10.10may identify additional subtle alterations in electrocortical activity in
Gabra5−/−mice.
Given the strong link between alterations in innate immunity and
ASD, we anticipated that Gabra5−/−mice possess altered baseline im-
mune activity (Onore et al., 2012). However, the effects of LPS on EEG
activity and sleep-wake behavior were similar in wild-type and
Gabra5−/−mice (at least at the level of EEG activity and sleep-wake be-
havior). It is important to note, however, that the marked baseline dif-
ferences in the EEG of Gabra5−/− mice (described above) could have
occluded further changes or made detection of genotype-dependent
changes difﬁcult, particularly if the changes occurred in the same direc-
tion. Future studies characterizing levels of cytokines, chemokines, and
other inﬂammatory factors in Gabra5−/− versuswild-typemice at base-
line and following an immune challenge will serve to further support or
refute the hypothesis that Gabra5−/− mice possess altered immune
activity.
In summary, our results are consistent with the notion that ASD is
associatedwith reduced GABAAR activity where extrasynaptic GABAARs
may play a dominant role. Gabra5−/−mice or experimental strategies
that reduce α5GABAAR function may serve as preclinical models for
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